Selection Committee

Selection Committee

Comprises domestic and international experts with extensive knowledge and experience in research and development of drugs, vaccines, and diagnostics. The Selection Committee is the key decision-making body in reviewing applications and awarding investments in this area. This committee evaluates investment proposals and reports from development partners, and recommends investments to the Board of Directors.


Paul Herrling

Former Head of Corporate Research at Novartis and the Chairman of the Board of the Novartis Institute for Tropical Diseases


Ann Mills-Duggan

Partner, Innovations, Wellcome Trust


Melissa Malhame

Principal, MM Global Health Consulting LLC


Insoo Kim

CEO/Founder, Eupidia Co., Ltd
Adjunct Professor, Sogang University


Christian Lienhardt

Research Director, French National Research Institute for Development (IRD, Institut de Recherche pour le Développement)


Gerald Voss

Executive Director
SciPeo Sprl, Science and People


Dan Wattendorf

Director of Innovative Technology Solutions, Bill and Melinda Gates Foundation


Joon Haeng Rhee

Professor of Microbiology, Chonnam National University Medical School